Yuki Togashi
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Kengo TakeuchiHiroyuki ManoManabu SodaSatoko HatanoYuichi IshikawaYoung Lim ChoiKen NakagawaSakae Okumura
- Topics
- Lung Cancer Treatments and Mutations (13 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers)Lung Cancer Research Studies (9 papers)
- Journals
- Nature MedicinePLoS ONECancer
- Partner nations
- JapanIndiaUnited States
In The Last Decade
Yuki Togashi
53 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 3.1k
- Oncology 2.3k
- Molecular Biology 1.6k
- Cancer Research 1.1k
- Pathology and Forensic Medicine 619
Countries citing papers authored by Yuki Togashi
This map shows the geographic impact of Yuki Togashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Togashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Togashi more than expected).
Fields of papers citing papers by Yuki Togashi
This network shows the impact of papers produced by Yuki Togashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Togashi. The network helps show where Yuki Togashi may publish in the future.
Co-authorship network of co-authors of Yuki Togashi
This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Togashi. A scholar is included among the top collaborators of Yuki Togashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Togashi. Yuki Togashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 10 | |
| 6 | 6 | |
| 7 | 8 | |
| 8 | 26 | |
| 9 | 56 | |
| 10 | 11 | |
| 11 | 205 | |
| 12 | 103 | |
| 13 | 77 | |
| 14 | 43 | |
| 15 | KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancerbreakdown → | 557 |
| 16 | 346 | |
| 17 | 397 | |
| 18 | 374 | |
| 19 | 16 | |
| 20 | 17 |
About Yuki Togashi
Yuki Togashi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 55 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.1k citations), Oncology (2.3k citations) and Cancer Research (1.1k citations). Yuki Togashi has collaborated with scholars based in Japan, India and United States. Frequent co-authors include Kengo Takeuchi, Hiroyuki Mano, Manabu Soda, Satoko Hatano, Yuichi Ishikawa, Young Lim Choi, Ken Nakagawa, Sakae Okumura, Yukitoshi Satoh and Kentaro Inamura. Their work appears in journals such as Nature Medicine, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.